Skip to main content

Intranasal Insulin May Have Pro-Cognitive Benefits

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, June 30, 2023 -- Intranasal insulin (INI) seems to have a beneficial effect on global cognition among patients with Alzheimer disease (AD)/mild cognitive impairment (MCI), according to a review published online June 28 in PLOS ONE.

Sally Wu, from the Center for Addiction and Mental Health at the University of Toronto, and colleagues conducted a systematic review and meta-analysis to examine the effects of INI on cognition in diverse patient populations and healthy individuals. Data were included from 29 studies with 1,726 healthy individuals and patients with AD/MCI, mental health disorders, and metabolic disorders.

The researchers found that an improvement in global cognition was more likely among patients with AD/MCI treated with INI (standardized mean difference, 0.22). No significant effects of INI were found for global cognition among healthy individuals and other patient populations.

"This systematic review and meta-analysis demonstrate that INI may be associated with pro-cognitive benefits, specifically for pooled global cognition. However, this effect is limited to patients with AD/MCI," the authors write. "As this is still a novel field of study, more research is required to understand the heterogeneity in treatment response of INI to extend the pro-cognitive benefits across different patient populations with the ultimate goal to improve their overall quality of life."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted June 2023

Read this next

First Responders With More Debris Exposure Have Higher Risk of Early Dementia

FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...

4.0 Percent of Seniors Had Received Dementia Diagnosis in 2022

THURSDAY, June 13, 2024 -- In 2022, 4.0 percent of adults aged 65 years and older reported ever having received a dementia diagnosis, with similar percentages seen for men and...

Lifestyle Intervention Can Improve Cognition, Function in Early Alzheimer Disease

THURSDAY, June 13, 2024 -- For patients with mild cognitive impairment (MCI) or early dementia due to Alzheimer disease (AD), comprehensive lifestyle changes may improve cognition...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.